Pulse pressure and stroke risk: development and validation of a new stroke risk model

Abstract Objective: This study aims to develop and validate a stroke risk model incorporating pulse pressure (PP) as a potential risk factor. Recent evidence suggests that PP, defined as the difference between systolic blood pressure (SBP) and diastolic blood pressure (DBP), could be an incremental...

Full description

Saved in:
Bibliographic Details
Published in:Current medical research and opinion Vol. 30; no. 12; pp. 2453 - 2460
Main Authors: Ayyagari, Rajeev, Vekeman, Francis, Lefebvre, Patrick, Ong, Siew Hwa, Faust, Elizabeth, Trahey, Alex, Machnicki, Gerardo, Duh, Mei Sheng
Format: Journal Article
Language:English
Published: England Informa UK Ltd 01-12-2014
Taylor & Francis
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Abstract Objective: This study aims to develop and validate a stroke risk model incorporating pulse pressure (PP) as a potential risk factor. Recent evidence suggests that PP, defined as the difference between systolic blood pressure (SBP) and diastolic blood pressure (DBP), could be an incremental risk factor beyond SBP. Methods: Electronic health records (EHRs) of hypertensive patients from a US integrated health delivery system were analyzed (January 2004 to May 2012). Patients with 1 PP reading and 6 months of observation prior to the first diagnosis of hypertension were randomly split into development (two-thirds of sample) and validation (one-third of sample) datasets. Stroke events were identified using ICD-9-CM 433.xx-436.xx. Cox proportional hazards models assessed time to first stroke event within 3 years of first hypertension diagnosis based on baseline risk factors, including PP, age, gender, diabetes, and cardiac comorbidities. The optimal model was selected using the least absolute shrinkage and selection operator (LASSO); performance was evaluated by the c-statistic. Results: Among 34,797 patients selected (mean age 59.3 years, 48% male), 4272 patients (12.3%) had a stroke. PP was higher among patients who developed stroke (mean [SD] PP, stroke: 02.0 [15.3] mmHg; non-stroke: 58.1 [14.0] mmHg, p < 0.001). The best performing risk model (c-statistic, development: 0.730; validation: 0.729) included PP (hazard ratio per mmHg increase: 1.0037, p < 0.001) as a significant risk factor. Limitations: This study was subject to limitations similar to other studies using EHRs. Only patient encounters occurring within the single healthcare network were captured in the data source. Though the model was tested internally, external validation (using a separate data source) would help assess the model's generalizability and calibration. Conclusions: This stroke risk model shows that greater PP is a significant predictive factor for increased stroke risk, even in the presence of known risk factors. PP should be considered by practitioners along with established risk factors in stroke treatment strategies.
AbstractList OBJECTIVEThis study aims to develop and validate a stroke risk model incorporating pulse pressure (PP) as a potential risk factor. Recent evidence suggests that PP, defined as the difference between systolic blood pressure (SBP) and diastolic blood pressure (DBP), could be an incremental risk factor beyond SBP.METHODSElectronic health records (EHRs) of hypertensive patients from a US integrated health delivery system were analyzed (January 2004 to May 2012). Patients with ≥ 1 PP reading and ≥ 6 months of observation prior to the first diagnosis of hypertension were randomly split into development (two-thirds of sample) and validation (one-third of sample) datasets. Stroke events were identified using ICD-9-CM 433.xx-436.xx. Cox proportional hazards models assessed time to first stroke event within 3 years of first hypertension diagnosis based on baseline risk factors, including PP, age, gender, diabetes, and cardiac comorbidities. The optimal model was selected using the least absolute shrinkage and selection operator (LASSO); performance was evaluated by the c-statistic.RESULTSAmong 34,797 patients selected (mean age 59.3 years, 48% male), 4272 patients (12.3%) had a stroke. PP was higher among patients who developed stroke (mean [SD] PP, stroke: 02.0 [15.3] mmHg; non-stroke: 58.1 [14.0] mmHg, p < 0.001). The best performing risk model (c-statistic, development: 0.730; validation: 0.729) included PP (hazard ratio per mmHg increase: 1.0037, p < 0.001) as a significant risk factor.LIMITATIONSThis study was subject to limitations similar to other studies using EHRs. Only patient encounters occurring within the single healthcare network were captured in the data source. Though the model was tested internally, external validation (using a separate data source) would help assess the model's generalizability and calibration.CONCLUSIONSThis stroke risk model shows that greater PP is a significant predictive factor for increased stroke risk, even in the presence of known risk factors. PP should be considered by practitioners along with established risk factors in stroke treatment strategies.
Abstract Objective: This study aims to develop and validate a stroke risk model incorporating pulse pressure (PP) as a potential risk factor. Recent evidence suggests that PP, defined as the difference between systolic blood pressure (SBP) and diastolic blood pressure (DBP), could be an incremental risk factor beyond SBP. Methods: Electronic health records (EHRs) of hypertensive patients from a US integrated health delivery system were analyzed (January 2004 to May 2012). Patients with 1 PP reading and 6 months of observation prior to the first diagnosis of hypertension were randomly split into development (two-thirds of sample) and validation (one-third of sample) datasets. Stroke events were identified using ICD-9-CM 433.xx-436.xx. Cox proportional hazards models assessed time to first stroke event within 3 years of first hypertension diagnosis based on baseline risk factors, including PP, age, gender, diabetes, and cardiac comorbidities. The optimal model was selected using the least absolute shrinkage and selection operator (LASSO); performance was evaluated by the c-statistic. Results: Among 34,797 patients selected (mean age 59.3 years, 48% male), 4272 patients (12.3%) had a stroke. PP was higher among patients who developed stroke (mean [SD] PP, stroke: 02.0 [15.3] mmHg; non-stroke: 58.1 [14.0] mmHg, p < 0.001). The best performing risk model (c-statistic, development: 0.730; validation: 0.729) included PP (hazard ratio per mmHg increase: 1.0037, p < 0.001) as a significant risk factor. Limitations: This study was subject to limitations similar to other studies using EHRs. Only patient encounters occurring within the single healthcare network were captured in the data source. Though the model was tested internally, external validation (using a separate data source) would help assess the model's generalizability and calibration. Conclusions: This stroke risk model shows that greater PP is a significant predictive factor for increased stroke risk, even in the presence of known risk factors. PP should be considered by practitioners along with established risk factors in stroke treatment strategies.
This study aims to develop and validate a stroke risk model incorporating pulse pressure (PP) as a potential risk factor. Recent evidence suggests that PP, defined as the difference between systolic blood pressure (SBP) and diastolic blood pressure (DBP), could be an incremental risk factor beyond SBP. Electronic health records (EHRs) of hypertensive patients from a US integrated health delivery system were analyzed (January 2004 to May 2012). Patients with ≥1 PP reading and ≥6 months of observation prior to the first diagnosis of hypertension were randomly split into development (two-thirds of sample) and validation (one-third of sample) datasets. Stroke events were identified using ICD-9-CM 433.xx-436.xx. Cox proportional hazards models assessed time to first stroke event within 3 years of first hypertension diagnosis based on baseline risk factors, including PP, age, gender, diabetes, and cardiac comorbidities. The optimal model was selected using the least absolute shrinkage and selection operator (LASSO); performance was evaluated by the c-statistic. Among 34,797 patients selected (mean age 59.3 years, 48% male), 4272 patients (12.3%) had a stroke. PP was higher among patients who developed stroke (mean [SD] PP, stroke: 02.0 [15.3] mmHg; non-stroke: 58.1 [14.0] mmHg, p < 0.001). The best performing risk model (c-statistic, development: 0.730; validation: 0.729) included PP (hazard ratio per mmHg increase: 1.0037, p < 0.001) as a significant risk factor. This study was subject to limitations similar to other studies using EHRs. Only patient encounters occurring within the single healthcare network were captured in the data source. Though the model was tested internally, external validation (using a separate data source) would help assess the model's generalizability and calibration. This stroke risk model shows that greater PP is a significant predictive factor for increased stroke risk, even in the presence of known risk factors. PP should be considered by practitioners along with established risk factors in stroke treatment strategies.
This study aims to develop and validate a stroke risk model incorporating pulse pressure (PP) as a potential risk factor. Recent evidence suggests that PP, defined as the difference between systolic blood pressure (SBP) and diastolic blood pressure (DBP), could be an incremental risk factor beyond SBP. Electronic health records (EHRs) of hypertensive patients from a US integrated health delivery system were analyzed (January 2004 to May 2012). Patients with ≥ 1 PP reading and ≥ 6 months of observation prior to the first diagnosis of hypertension were randomly split into development (two-thirds of sample) and validation (one-third of sample) datasets. Stroke events were identified using ICD-9-CM 433.xx-436.xx. Cox proportional hazards models assessed time to first stroke event within 3 years of first hypertension diagnosis based on baseline risk factors, including PP, age, gender, diabetes, and cardiac comorbidities. The optimal model was selected using the least absolute shrinkage and selection operator (LASSO); performance was evaluated by the c-statistic. Among 34,797 patients selected (mean age 59.3 years, 48% male), 4272 patients (12.3%) had a stroke. PP was higher among patients who developed stroke (mean [SD] PP, stroke: 02.0 [15.3] mmHg; non-stroke: 58.1 [14.0] mmHg, p < 0.001). The best performing risk model (c-statistic, development: 0.730; validation: 0.729) included PP (hazard ratio per mmHg increase: 1.0037, p < 0.001) as a significant risk factor. This study was subject to limitations similar to other studies using EHRs. Only patient encounters occurring within the single healthcare network were captured in the data source. Though the model was tested internally, external validation (using a separate data source) would help assess the model's generalizability and calibration. This stroke risk model shows that greater PP is a significant predictive factor for increased stroke risk, even in the presence of known risk factors. PP should be considered by practitioners along with established risk factors in stroke treatment strategies.
Author Ayyagari, Rajeev
Vekeman, Francis
Machnicki, Gerardo
Lefebvre, Patrick
Duh, Mei Sheng
Trahey, Alex
Ong, Siew Hwa
Faust, Elizabeth
Author_xml – sequence: 1
  givenname: Rajeev
  surname: Ayyagari
  fullname: Ayyagari, Rajeev
  email: Mei.Duh@analysisgroup.com, Mei.Duh@analysisgroup.com
  organization: Analysis Group Inc
– sequence: 2
  givenname: Francis
  surname: Vekeman
  fullname: Vekeman, Francis
  email: Mei.Duh@analysisgroup.com, Mei.Duh@analysisgroup.com
  organization: Groupe d'analyse Ltée
– sequence: 3
  givenname: Patrick
  surname: Lefebvre
  fullname: Lefebvre, Patrick
  email: Mei.Duh@analysisgroup.com, Mei.Duh@analysisgroup.com
  organization: Groupe d'analyse Ltée
– sequence: 4
  givenname: Siew Hwa
  surname: Ong
  fullname: Ong, Siew Hwa
  email: Mei.Duh@analysisgroup.com, Mei.Duh@analysisgroup.com
  organization: Novartis Pharma AG
– sequence: 5
  givenname: Elizabeth
  surname: Faust
  fullname: Faust, Elizabeth
  email: Mei.Duh@analysisgroup.com, Mei.Duh@analysisgroup.com
  organization: Analysis Group Inc
– sequence: 6
  givenname: Alex
  surname: Trahey
  fullname: Trahey, Alex
  email: Mei.Duh@analysisgroup.com, Mei.Duh@analysisgroup.com
  organization: Analysis Group Inc
– sequence: 7
  givenname: Gerardo
  surname: Machnicki
  fullname: Machnicki, Gerardo
  email: Mei.Duh@analysisgroup.com, Mei.Duh@analysisgroup.com
  organization: Novartis Argentina SA
– sequence: 8
  givenname: Mei Sheng
  surname: Duh
  fullname: Duh, Mei Sheng
  email: Mei.Duh@analysisgroup.com, Mei.Duh@analysisgroup.com
  organization: Analysis Group Inc
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25265131$$D View this record in MEDLINE/PubMed
BookMark eNqFkE1P3DAQhq2Kqiwf_wBVPvaSrcdO4oQDFUL9kpDKAc7WrD0RAcde7ATEv2-2C6hc4DSHed53Rs8e2wkxEGNHIJYATfVVKCF021ZLKaBcthpUpT-wBZRaFWWj9Q5bbJBiw-yyvZxvhADZtO0ntisrWVegYMGuLiafia8T5Twl4hgcz2OKt8RTn2-PuaN78nE9UBj_Le_R9w7HPgYeO4480MP_AT5ER_6Afexw7j18mvvs6sf3y7Nfxfmfn7_PTs8LW0IzFtgikFXSrqSlrm6p1sIpWQpU2kJDzoFrbT1TQoMtydVSWmexdF1tV4hqn33Z9q5TvJsoj2bosyXvMVCcsoFaNk0DIOoZLbeoTTHnRJ1Zp37A9GhAmI1Q8yzUbISardA59vnpwrQayL2Eng3OwLct0IcupgEfYvLOjPjoY-oSBttno945cfKq4ZrQj9cWE5mbOKUwC3z7x78_B5tg
CitedBy_id crossref_primary_10_1093_jamia_ocw042
crossref_primary_10_1161_JAHA_118_010811
crossref_primary_10_1097_HJH_0000000000001268
crossref_primary_10_1155_2022_6956406
crossref_primary_10_1097_HJH_0000000000002442
crossref_primary_10_1097_MD_0000000000009233
crossref_primary_10_1093_ajh_hpx025
crossref_primary_10_1007_s10143_023_02256_1
crossref_primary_10_1016_j_ijmedinf_2020_104272
crossref_primary_10_1155_2023_5517493
crossref_primary_10_1007_s00392_016_0972_2
crossref_primary_10_1097_JCN_0000000000000541
Cites_doi 10.1038/ki.2012.131
10.1161/hy1001.092966
10.1093/ajh/hps092
10.1161/01.CIR.96.1.308
10.1001/jama.1982.03320300037019
10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3
10.1016/0002-9149(76)90061-8
10.1016/S0895-4356(01)00434-6
10.1161/CIRCULATIONAHA.108.823112
10.1161/01.STR.22.3.312
10.1161/01.HYP.34.3.375
10.1097/00004872-200018040-00010
10.1161/STR.0b013e3181fcb238
10.1161/01.STR.11.1.14
10.1001/archinte.160.8.1085
10.1161/01.HYP.23.3.395
10.1093/eurheartj/eht151
10.1001/jama.284.7.876
10.1161/01.HYP.0000145108.23948.7b
10.1161/CIR.0b013e31823ac046
10.1161/01.HYP.38.2.232
10.2307/3349563
10.1038/sj.jhh.1001669
10.1161/01.CIR.103.21.2579
10.1016/S0895-7061(01)02044-1
10.1161/CIRCULATIONAHA.111.069633
10.1161/HYPERTENSIONAHA.112.201400
10.1002/sim.4154
10.1161/01.CIR.100.4.354
ContentType Journal Article
Copyright 2014 All rights reserved: reproduction in whole or part not permitted 2014
Copyright_xml – notice: 2014 All rights reserved: reproduction in whole or part not permitted 2014
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1185/03007995.2014.971357
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1473-4877
EndPage 2460
ExternalDocumentID 10_1185_03007995_2014_971357
25265131
971357
Genre Research Articles
Validation Studies
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.55
.GJ
00X
03L
08R
0BK
0R~
29F
34G
39C
3V.
4.4
53G
5GY
5RE
6J9
6PF
7X7
88E
88I
8AF
8AO
8FI
8FJ
8R4
8R5
AAJNR
AALIY
AALUX
AAMIU
AAPUL
AAPXX
AAQRR
AAUGY
AAWTL
ABBAB
ABBKH
ABEIZ
ABIVO
ABLJU
ABLKL
ABOCM
ABPTK
ABUPF
ABUWG
ABWCV
ABZEW
ACENM
ACFUF
ACGFO
ACGFS
ACGOD
ACKZS
ACLSK
ADBBV
ADCVX
ADFCX
ADFOM
ADFZZ
ADRBQ
AECIN
AEIIZ
AENEX
AEOZL
AEYQI
AFKRA
AFLEI
AFWLO
AGDLA
AGFJD
AGRBW
AGYJP
AHMBA
AIJEM
AIRBT
AJVHN
AKBVH
ALIIL
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AMDAE
AZQEC
BABNJ
BENPR
BLEHA
BOHLJ
BPHCQ
BRMBE
BVXVI
CAG
CCCUG
COF
CS3
CYYVM
CZDIS
DKSSO
DRXRE
DU5
DWQXO
DWTOO
EBS
EJD
F5P
FYUFA
GNUQQ
H13
HCIFZ
HZ~
IPNFZ
J5H
JENTW
KRBQP
KSSTO
KWAYT
KYCEM
L7B
LJTGL
M1P
M2P
M2Q
M44
M4Z
O9-
P2P
PQEST
PQQKQ
PQUKI
PROAC
PSQYO
Q2X
QQXMO
RIG
RNANH
RVRKI
RWL
S0X
SJN
TAE
TFDNU
TFL
TFW
UEQFS
UKHRP
V1S
X7M
ZGI
~1N
AAORF
ABJNI
ABLIJ
ABXYU
ACIEZ
ALIPV
ALYBC
CCPQU
CGR
CUY
CVF
ECM
EIF
EMOBN
HMCUK
NPM
NUSFT
TBQAZ
TDBHL
TERGH
TUROJ
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c418t-a9a1ec32cb2cef69e670d3240a37c18edd1d9c69a1071c4ed622cdca4df6cbaa3
ISSN 0300-7995
IngestDate Fri Oct 25 06:43:31 EDT 2024
Thu Nov 21 21:56:57 EST 2024
Tue Oct 15 23:48:46 EDT 2024
Tue Jun 13 20:00:57 EDT 2023
Wed Jun 21 08:14:28 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords Hypertension
Pulse pressure
Risk prediction
Stroke
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c418t-a9a1ec32cb2cef69e670d3240a37c18edd1d9c69a1071c4ed622cdca4df6cbaa3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 25265131
PQID 1628881106
PQPubID 23479
PageCount 8
ParticipantIDs informahealthcare_journals_10_1185_03007995_2014_971357
pubmed_primary_25265131
proquest_miscellaneous_1628881106
informaworld_taylorfrancis_310_1185_03007995_2014_971357
crossref_primary_10_1185_03007995_2014_971357
PublicationCentury 2000
PublicationDate 20141200
12/1/2014
2014-Dec
2014-12-01
20141201
PublicationDateYYYYMMDD 2014-12-01
PublicationDate_xml – month: 12
  year: 2014
  text: 20141200
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Current medical research and opinion
PublicationTitleAlternate Curr Med Res Opin
PublicationYear 2014
Publisher Informa UK Ltd
Taylor & Francis
Publisher_xml – name: Informa UK Ltd
– name: Taylor & Francis
References CIT0030
CIT0010
CIT0012
CIT0011
The Australian therapeutic trial in mild hypertension (CIT0009) 1980; 1
CIT0014
CIT0013
CIT0016
CIT0015
CIT0018
CIT0017
CIT0019
CIT0021
CIT0020
CIT0001
CIT0023
CIT0022
Uno H (CIT0025) 2011; 30
CIT0003
CIT0002
CIT0024
CIT0005
CIT0027
CIT0004
CIT0026
CIT0007
CIT0029
CIT0006
CIT0028
CIT0008
References_xml – ident: CIT0019
  doi: 10.1038/ki.2012.131
– ident: CIT0015
  doi: 10.1161/hy1001.092966
– ident: CIT0012
  doi: 10.1093/ajh/hps092
– ident: CIT0013
  doi: 10.1161/01.CIR.96.1.308
– ident: CIT0008
  doi: 10.1001/jama.1982.03320300037019
– ident: CIT0024
  doi: 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3
– ident: CIT0004
  doi: 10.1016/0002-9149(76)90061-8
– ident: CIT0023
  doi: 10.1016/S0895-4356(01)00434-6
– ident: CIT0029
  doi: 10.1161/CIRCULATIONAHA.108.823112
– volume: 1
  start-page: 1261
  year: 1980
  ident: CIT0009
  publication-title: Lancet
  contributor:
    fullname: The Australian therapeutic trial in mild hypertension
– ident: CIT0022
  doi: 10.1161/01.STR.22.3.312
– ident: CIT0020
  doi: 10.1161/01.HYP.34.3.375
– ident: CIT0027
  doi: 10.1097/00004872-200018040-00010
– ident: CIT0001
  doi: 10.1161/STR.0b013e3181fcb238
– ident: CIT0005
  doi: 10.1161/01.STR.11.1.14
– ident: CIT0021
  doi: 10.1001/archinte.160.8.1085
– ident: CIT0016
  doi: 10.1161/01.HYP.23.3.395
– ident: CIT0011
  doi: 10.1093/eurheartj/eht151
– ident: CIT0026
  doi: 10.1001/jama.284.7.876
– ident: CIT0028
  doi: 10.1161/01.HYP.0000145108.23948.7b
– ident: CIT0002
  doi: 10.1161/CIR.0b013e31823ac046
– ident: CIT0030
  doi: 10.1161/01.HYP.38.2.232
– ident: CIT0006
  doi: 10.2307/3349563
– ident: CIT0018
  doi: 10.1038/sj.jhh.1001669
– ident: CIT0010
  doi: 10.1161/01.CIR.103.21.2579
– ident: CIT0017
  doi: 10.1016/S0895-7061(01)02044-1
– ident: CIT0003
  doi: 10.1161/CIRCULATIONAHA.111.069633
– ident: CIT0007
  doi: 10.1161/HYPERTENSIONAHA.112.201400
– volume: 30
  start-page: 1105
  year: 2011
  ident: CIT0025
  publication-title: Stat Med
  doi: 10.1002/sim.4154
  contributor:
    fullname: Uno H
– ident: CIT0014
  doi: 10.1161/01.CIR.100.4.354
SSID ssj0012899
Score 2.2146096
Snippet Abstract Objective: This study aims to develop and validate a stroke risk model incorporating pulse pressure (PP) as a potential risk factor. Recent evidence...
This study aims to develop and validate a stroke risk model incorporating pulse pressure (PP) as a potential risk factor. Recent evidence suggests that PP,...
OBJECTIVEThis study aims to develop and validate a stroke risk model incorporating pulse pressure (PP) as a potential risk factor. Recent evidence suggests...
SourceID proquest
crossref
pubmed
informaworld
informahealthcare
SourceType Aggregation Database
Index Database
Publisher
StartPage 2453
SubjectTerms Aged
Blood Pressure - physiology
Electronic Health Records
Female
Humans
Hypertension
Hypertension - complications
Hypertension - physiopathology
Male
Middle Aged
Proportional Hazards Models
Pulse pressure
Reproducibility of Results
Retrospective Studies
Risk Factors
Risk prediction
Stroke
Stroke - etiology
Stroke - physiopathology
Title Pulse pressure and stroke risk: development and validation of a new stroke risk model
URI https://www.tandfonline.com/doi/abs/10.1185/03007995.2014.971357
https://www.ncbi.nlm.nih.gov/pubmed/25265131
https://search.proquest.com/docview/1628881106
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELe6TUK8oPFdvmQk3lCgcbw44a0aRX3ZQNAh3izHHwOmtWhth_bfc2c7iVn5lniJorjutb5f7s6-L0Ke5KZCS8BkoHxVxmEDkClQDHDXcKZyxozAbOTpO3H4oXo54ZPBoO0c0z_7r5yGZ8BrzJz9C253XwoP4B54DlfgOlz_iO9v1qDsnvrw1tY3sFydLU6sjyLHAwDTxwn5YaD-yXSWo8Im4-mU0CwnNWLbmk6n0ckTCwaFHDlMwEp8--OLC3WsQjr7W_XZ2vN25L09sfH4NXb36IODnG3OY_qZbyHQpRO9jqfbmG4z_arSM4ucX4r_mG20D0mkXjEaZVilLiioIJW5KDLYWYlUbEd3ToQnS4UwD_WHo0JnPHQs2FQWla-rAQSRHob58Wc1tiwUvXLsQhbDwBbZYSDRQKDujPcnhwedwwr3rcFhFX59zNIEEs9_ROA7K2g31sj92EX8Xaqb-_Pdj7eCZrvkWty-0HHA3XUysPMb5MpBDNC4SY48_GgLPwqIoAFLFLH0gibg84M9-OjCUUUBfOkE6sF3ixy9msz2p1ns3JFpnlerTNUqt7pgumHaurK2pRgZLP2oCqHzyhqTm1qX8CmwcDW3pmRMG624caVulCpuk-35Ym7vEsqdc6B3ajA7Ba_hGxtRWVeLorCYo10PSdaupPwSCrRIv7Gt9mS78hJXXoaVHxKxsdwyvr_L38ysUqbIlUexCwCWxa-nPm4ZKEF8o09Oze1iDQSx3XcFNng5JHcCZ7u_wbB1RV7k9_6d8H1ytX__HpDt1dnaPiRbS7N-FBH8DeNywmY
link.rule.ids 315,782,786,27933,27934,59868,60657,61275,61456
linkProvider Taylor & Francis
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1ZSwMxEB60gvrifdQzgq-r3cNN1reiLRXbIqjgW0hzoAittN3_78xmWy9UEN8WspOQZCYzycx8A3AcGkGWgAlQ-aogwQtAoFAx4FcviVQYRYZTNnLrlncfxGWDYHLqk1wYCqukO7TzQBHFWU3CTY_RXsLF2SkyZo2AzCgyKznJqMocn4U5ghoXFZirXzS6nakrgW4U3pVQC4iozJ_7rp8P-mmlRC99nMZifUI0_d4uLfRTc_kfZrYCS6Vxyuqem1ZhxvbXYL5Tut_X4f4mR03KitjZfGgZjsNG4-Hg2TIKUT9n5i0EqWhENn7yRZvYwDHF0IZ_T8CKOjwbcN9s3F20grIuQ6CTUIwDlanQ6jjSvUhbl2Y25TVDwH4q5joU1pjQZDrFv9B-0Yk1aRRpo1ViXKp7SsWbUOkP-nYbWOKcw1MlQ6OCJxn22OPCuozHsaUM3KwKwWQ35IuH35DFtUWcyclaSVor6deqCvzLlslSKke_UIr3GyvHxYOJ89VNZPwz6dGECSQKJ3lcVN8OchyQijkLtLDSKmx57phOI6LCBGEc7vx94ENYaN112rJ91b3ehUVq8ZE2e1AZD3O7D7Mjkx-UEvEKz1EFqw
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ZSwMxEB48oPii9a5nBF9Xu0c3Wd-kB4paBBV8C2kOFKEtbff_O7PZ1gsV9G0hOwmbzGS-2bkAjkMjCAmYAJWvChI0AAKFigGfekmkwigynLKRL-5491G02lQmZ5bFT2GVZEM7XyiiuKtJuIfGeQEXjVPkyzrVMaPArOQkoyZzfB4WEYo30PxaPG-2uzczTwIZFN6TUA-IqEyf-26eD-qpWhYvfZqFYn0qaPo9LC3UU2fl_x9WheUSmrJzz0urMGf7a1C5KZ3v6_Bwm6MeZUXkbD6yDJdh48lo8GIZBaifMfMWgFQMIhM_-5ZNbOCYYojg3xOwogvPBjx02vfNi6DsyhDoJBSTQGUqtDqOdC_S1qWZTXndUFk_FXMdCmtMaDKd4luIXnRiTRpF2miVGJfqnlLxJiz0B327DSxxzuGdkiGk4EmGM_a4sC7jcWwp_zarQTA9DDn0xTdkYbSIhpzulaS9kn6vasC_nJgsZXL8C6V4f65yUvwucb63iYx_Jj2a8oBE0SR_i-rbQY4LUitngfgqrcGWZ47ZZ0TUliCMw52_L3wIldtWR15fdq92YYkGfJjNHixMRrndh_mxyQ9KeXgFhSsETw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pulse+pressure+and+stroke+risk%3A+development+and+validation+of+a+new+stroke+risk+model&rft.jtitle=Current+medical+research+and+opinion&rft.au=Ayyagari%2C+Rajeev&rft.au=Vekeman%2C+Francis&rft.au=Lefebvre%2C+Patrick&rft.au=Ong%2C+Siew+Hwa&rft.date=2014-12-01&rft.pub=Taylor+%26+Francis&rft.issn=0300-7995&rft.eissn=1473-4877&rft.volume=30&rft.issue=12&rft.spage=2453&rft.epage=2460&rft_id=info:doi/10.1185%2F03007995.2014.971357&rft.externalDocID=971357
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-7995&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-7995&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-7995&client=summon